Long-term safety of adalimumab (humira®) in worldwide rheumatoid arthritis clinical trials

被引：0
|
作者：
Schiff, MH
Burmester, GR
Pangan, A
Kupper, H
Spencer-Green, GT
机构：
[1] Denver Arthrit Clin PC, Denver, CO USA
[2] Univ Klinikum Charite, Berlin, Germany
[3] Abbott Labs, Abbott Pk, IL 60064 USA
[4] Abbott GmbH & Co KG, Ludwigshafen, Germany
[5] Abbott Labs, Parsippany, NJ USA
来源：
RHEUMATOLOGY | 2005年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I70 / I71
页数：2
相关论文
共 50 条
  • [1] Global safety in adalimumab (HUMIRA®) rheumatoid arthritis clinical trials.
    Schiff, MH
    Burmester, GR
    Pangan, AL
    Kupper, H
    Spencer-Green, GT
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S562 - S562
  • [2] Long-term safety of fully human anti-TNF adalimumab in worldwide rheumatoid arthritis clinical trials
    Schiff, MH
    Burmester, GR
    Pangan, AL
    Kupper, H
    Spencer-Green, G
    Kent, JD
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S297 - S297
  • [3] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Taylor, A.
    Nash, P.
    Hall, S.
    Jones, G.
    Youssef, P.
    Porter-Brown, B.
    Thompson, L.
    Genovese, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2012, 42 : 14 - 14
  • [4] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    Van Vollenhoven, Ronald
    [J]. RHEUMATOLOGY, 2012, 51 : 75 - 76
  • [5] Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis
    Schiff, M. H.
    Burmester, G. R.
    Kent, J. D.
    Pangan, A. L.
    Kupper, H.
    Fitzpatrick, S. B.
    Donovan, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (07) : 889 - 894
  • [6] Long-Term Safety of Tocilizumab in Rheumatoid Arthritis Clinical Trials.
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    van Vollenhoven, Ronald F.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S866 - S866
  • [7] Safety of adalimumab (HUMIRA®) in global clinical trials of patients with early vs. long-standing rheumatoid arthritis (RA)
    Schiff, MH
    Burmester, GR
    Pangan, AL
    Kupper, H
    Spencer-Green, GT
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 422 - +
  • [8] Safety of adalimumab in long-term treatment of patients with rheumatoid arthritis
    Schiff, M
    Burmester, GR
    Kent, J
    Pangan, A
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P203 - P203
  • [9] Long-term efficacy, remission, and safety of adalimumab (HUMIRA®) plus methotrexate in patients with rheumatoid arthritis in the ARMADA trial.
    Weinblatt, ME
    Keystone, EC
    Furst, DE
    Kavanaugh, AF
    Chartash, EK
    Segurado, OG
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S563 - S563
  • [10] Adalimumab (Humira) for rheumatoid arthritis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1153): : 25 - 27
12345